Clinical trial
Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and…
NCT00463801 · Novartis, Industry · Terminated
Key facts
| NCT number | NCT00463801 |
|---|---|
| Title | Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-structure Infections |
| Official title | A Multicentre, Open Label, Uncontrolled Clinical Trial to Evaluate Efficacy and Safety of Daptomycin for the Treatment of Complicated Skin and Skin-Structure Infections (cSSTI) Caused by Methicillin-resistant Staphylococcus Aureus (MRSA) |
| Lead sponsor | Novartis, Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Staphylococcal Skin Infections |
| Intervention type | Drug |
| Interventions | Daptomycin |
| Enrollment | 52 |
| Start date | Jan 1, 2007 |
| Primary completion | Nov 1, 2007 |
| First posted | Apr 20, 2007 |
| Last update posted | Mar 24, 2011 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: